↓ Skip to main content

Cochrane Database of Systematic Reviews

Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension

Overview of attention for article published in this source, October 2009
Altmetric Badge

Mentioned by

3 Facebook pages
3 Wikipedia pages


59 Dimensions

Readers on

67 Mendeley
1 CiteULike
1 Connotea
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Published by
John Wiley & Sons, Ltd, October 2009
DOI 10.1002/14651858.cd007435.pub2
Pubmed ID

Ho, Meghan J, Bellusci, Anthony, Wright, James M


Studies have shown that coenzyme Q10 deficiency is associated with cardiovascular disease. Hypertension is a commonly measured surrogate marker for non-fatal and fatal cardiovascular endpoints such as heart attacks and strokes. Clinical trials have suggested that coenzyme Q10 supplementation can effectively lower blood pressure (BP).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 2 3%
Canada 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 22%
Researcher 12 18%
Student > Master 11 16%
Student > Postgraduate 8 12%
Student > Ph. D. Student 5 7%
Other 10 15%
Unknown 6 9%
Readers by discipline Count As %
Medicine and Dentistry 35 52%
Nursing and Health Professions 10 15%
Agricultural and Biological Sciences 8 12%
Biochemistry, Genetics and Molecular Biology 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 1 1%
Unknown 7 10%